Accelerate Diagnostics, Inc.

General ticker "AXDX" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $30.0M (TTM average)

Accelerate Diagnostics, Inc. follows the US Stock Market performance with the rate: 4.7%.

Estimated limits based on current volatility of 2217.6%: low -0.01$, high 0.01$

Factors to consider:

  • US accounted for 88.0% of revenue in the fiscal year ended 2023-12-31
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.18$, 4.25$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.85$, 3.13$]

Financial Metrics affecting the AXDX estimates:

  • Negative: Non-GAAP EPS, $ of -2.34 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -42.85 <= 1.76
  • Negative: negative Operating income
  • Negative: Shareholder equity ratio, % of -196.25 <= 22.51
  • Negative: Industry earnings per price (median), % of -5.14 <= 0
  • Positive: Interest expense per share, $ of 0.56 <= 0.67
  • Positive: Industry inventory ratio change (median), % of -0.33 <= -0.29

Similar symbols

Short-term AXDX quotes

Long-term AXDX plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $12.75MM $12.06MM $11.70MM
Operating Expenses $75.56MM $66.09MM $47.01MM
Operating Income $-62.80MM $-54.03MM $-35.31MM
Non-Operating Income $0.23MM $-6.74MM $-14.80MM
Interest Expense $3.77MM $7.74MM $13.12MM
R&D Expense $26.91MM $25.35MM $16.69MM
Income(Loss) $-62.57MM $-60.77MM $-50.11MM
Taxes $-0.08MM $0.85MM $-0.07MM
Profit(Loss)* $-62.49MM $-61.62MM $-50.05MM
Stockholders Equity $-22.26MM $-19.89MM $-56.04MM
Inventory $5.19MM $3.31MM $2.85MM
Assets $65.02MM $31.37MM $28.56MM
Operating Cash Flow $-48.73MM $-40.20MM $-24.19MM
Capital expenditure $0.55MM $1.03MM $0.00MM
Investing Cash Flow $12.42MM $8.66MM $-0.51MM
Financing Cash Flow $31.63MM $9.02MM $27.05MM
Earnings Per Share** $-7.61 $-4.94 $-2.15

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.